{"id":"minocycline-hydrochloride-capsules","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Vomiting"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Photosensitivity"},{"rate":null,"effect":"Dizziness or vertigo"},{"rate":null,"effect":"Vaginal candidiasis"}]},"_chembl":{"chemblId":"CHEMBL1200881","moleculeType":"Small molecule","molecularWeight":"493.94"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Minocycline hydrochloride is a second-generation tetracycline antibiotic that penetrates bacterial cells and binds to the 30S ribosomal subunit, blocking aminoacyl-tRNA from entering the A site and preventing peptide bond formation. This inhibition of protein synthesis is bacteriostatic, stopping bacterial growth and allowing the immune system to clear the infection. Minocycline has broad-spectrum activity against gram-positive and gram-negative bacteria, as well as some atypical organisms.","oneSentence":"Minocycline is a tetracycline antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:21:28.325Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial infections susceptible to tetracyclines (acne, respiratory infections, urinary tract infections, rickettsial infections)"}]},"trialDetails":[{"nctId":"NCT03947827","phase":"PHASE3","title":"Minocycline as Adjunctive Treatment for Treatment Resistant Depression","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2020-02-01","conditions":"Treatment Resistant Depression","enrollment":76},{"nctId":"NCT06120140","phase":"PHASE2","title":"Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2024-02-16","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":300},{"nctId":"NCT05367362","phase":"PHASE2","title":"Minocycline Efficacy in Improving Neurological Outcome of Patients Who Undergo Endovascular Revascularization for Acute Ischemic Stroke","status":"WITHDRAWN","sponsor":"State University of New York at Buffalo","startDate":"2025-12-01","conditions":"Acute Ischemic Stroke","enrollment":""},{"nctId":"NCT05902819","phase":"NA","title":"Reconsolidation Blockade of Intrusive Trauma- and Cocaine-related Memories","status":"COMPLETED","sponsor":"Psychiatric University Hospital, Zurich","startDate":"2023-05-10","conditions":"Post-traumatic Stress Disorder, Cocaine Use Disorder","enrollment":138},{"nctId":"NCT06889701","phase":"PHASE1, PHASE2","title":"A Phase 1/2 Study to Evaluate the Safety, PK and Efficacy of TNP-2092 Administered Via IA Injection in PJI Participants","status":"RECRUITING","sponsor":"TenNor Therapeutics Inc.","startDate":"2025-04-03","conditions":"Periprosthetic Joint Infection (PJI)","enrollment":33},{"nctId":"NCT03106740","phase":"PHASE2","title":"Evaluating the Role of Neuroinflammation in Low Back Pain","status":"COMPLETED","sponsor":"Marco Loggia","startDate":"2017-10-10","conditions":"Low Back Pain, Back Pain With Radiation, Back Pain Without Radiation","enrollment":60},{"nctId":"NCT07338175","phase":"PHASE3","title":"Efficacy and Safety of Minocycline in Acute Spontaneous Intracerebral Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-01","conditions":"Intracerebral Hemorrhage","enrollment":1192},{"nctId":"NCT07305896","phase":"NA","title":"Efficacy and Safety of Minocycline in the Treatment of Intracerebral Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"The First Hospital of Jilin University","startDate":"2025-12-31","conditions":"Intracerebral Hemorrhage","enrollment":1248},{"nctId":"NCT05826912","phase":"PHASE2","title":"Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury","status":"ENROLLING_BY_INVITATION","sponsor":"University of California, San Francisco","startDate":"2024-08-01","conditions":"Traumatic Brain Injury","enrollment":672},{"nctId":"NCT02564978","phase":"PHASE2","title":"Evaluation of Oral Minocycline in the Treatment of Geographic Atrophy Associated With Age-Related Macular Degeneration","status":"COMPLETED","sponsor":"National Eye Institute (NEI)","startDate":"2016-12-14","conditions":"Age-Related Macular Degeneration","enrollment":37},{"nctId":"NCT07082855","phase":"PHASE3","title":"A Multicenter, Randomized, Double-Blind, Controlled Clinical Study of Minocycline for the Treatment of Retinitis Pigmentosa","status":"NOT_YET_RECRUITING","sponsor":"Zhongshan Ophthalmic Center, Sun Yat-sen University","startDate":"2025-07-15","conditions":"Retinitis Pigmentosa, Inherited Retinal Dystrophy, Retina Disorder","enrollment":126},{"nctId":"NCT02719392","phase":"PHASE4","title":"A Pilot Study Investigating the Efficacy of Minocycline and N-Acetyl Cysteine for Bipolar Depression","status":"SUSPENDED","sponsor":"Massachusetts General Hospital","startDate":"2017-08-09","conditions":"Bipolar Disorder, Bipolar Depression","enrollment":40},{"nctId":"NCT05836740","phase":"PHASE3","title":"Efficacy and Safety of Minocycline in Patients With Moderate to Severe Acute Ischemic Stroke","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2023-05-19","conditions":"Ischemic Stroke, Acute","enrollment":1724},{"nctId":"NCT06818578","phase":"PHASE4","title":"Success of Lesion Sterilization and Tissue Repair Therapy","status":"COMPLETED","sponsor":"Inonu University","startDate":"2022-09-14","conditions":"Primary Teeth, Pulp Necrosis, Pulpitis - Irreversible","enrollment":58},{"nctId":"NCT02515955","phase":"PHASE1","title":"A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-54175446 in Healthy Male Participants","status":"COMPLETED","sponsor":"Janssen-Cilag International NV","startDate":"2015-08","conditions":"Healthy","enrollment":76},{"nctId":"NCT05605366","phase":"PHASE1","title":"Minocycline in Neurocognitive Outcomes - Sickle Cell Disease","status":"NOT_YET_RECRUITING","sponsor":"University of Cincinnati","startDate":"2025-06-01","conditions":"Sickle Cell Disease, Cognitive Impairment, Cognitive Decline","enrollment":30},{"nctId":"NCT05644301","phase":"PHASE3","title":"INflammation-based Stratification for Immune-Targeted Augmentation in Major Depressive Disorder","status":"RECRUITING","sponsor":"Universiteit Antwerpen","startDate":"2023-09-21","conditions":"Major Depressive Disorder, Inflammation","enrollment":240},{"nctId":"NCT06307288","phase":"PHASE4","title":"Efficacy and Safety of Tranilast Combined With Minocycline in the Treatment of Rosacea","status":"ENROLLING_BY_INVITATION","sponsor":"Second Affiliated Hospital of Xi'an Jiaotong University","startDate":"2023-10-16","conditions":"Rosacea","enrollment":45},{"nctId":"NCT06207760","phase":"PHASE2","title":"Effect of Minocycline on Inflammation in Depressed Patients","status":"UNKNOWN","sponsor":"IRCCS Centro San Giovanni di Dio Fatebenefratelli","startDate":"2023-08-28","conditions":"Depression","enrollment":60},{"nctId":"NCT03320018","phase":"PHASE2, PHASE3","title":"Neuroprotection in Acute Ischemic Stroke","status":"COMPLETED","sponsor":"Stony Brook University","startDate":"2017-08-02","conditions":"Stroke, Ischemic","enrollment":15},{"nctId":"NCT05597462","phase":"PHASE1","title":"Impact of DFD-29 on Microbial Flora of Healthy, Adult Human Subjects When Administered Over 16 Weeks","status":"COMPLETED","sponsor":"Journey Medical Corporation","startDate":"2022-09-30","conditions":"Rosacea","enrollment":60},{"nctId":"NCT04940767","phase":"PHASE4","title":"A Companion Treatment Study for Patients With Moderate to Severe Acne Vulgaris","status":"COMPLETED","sponsor":"Edward Lain, MD","startDate":"2021-06-28","conditions":"Acne Vulgaris","enrollment":31},{"nctId":"NCT05474950","phase":"PHASE1, PHASE2","title":"Minocycline Treatment for Cystoid Macular Edema","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2019-01-01","conditions":"Minocycline, Cystoid Macular Edema","enrollment":5},{"nctId":"NCT05474729","phase":"PHASE1, PHASE2","title":"Minocycline for Chronic Autoimmune Uveitis","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2021-12-01","conditions":"Minocycline, Uveitis, Retinal Degeneration","enrollment":10},{"nctId":"NCT05452785","phase":"PHASE1","title":"A Comparative Bioavailability Study of DFD-29 Capsules 40 mg Versus SOLODYN® Tablets 105 mg, Under Fasting & Fed Conditions in Healthy Adult Human Subjects","status":"COMPLETED","sponsor":"Journey Medical Corporation","startDate":"2022-05-07","conditions":"Pharmacokinetics","enrollment":24},{"nctId":"NCT05586815","phase":"PHASE4","title":"Efficacy of Colistin Monotherapy Versus Colistin Plus Minocycline for Carbapenem-Resistant A. Baumannii Infection","status":"UNKNOWN","sponsor":"Mahidol University","startDate":"2023-01-10","conditions":"Acinetobacter Infections","enrollment":94},{"nctId":"NCT05575427","phase":"PHASE4","title":"Efficacy of Combination Therapy With Minocycline for Treatment of Stenotrophomonas Maltophilia Infections","status":"UNKNOWN","sponsor":"Mahidol University","startDate":"2022-11-24","conditions":"Hospital Infections","enrollment":112},{"nctId":"NCT01874860","phase":"PHASE2","title":"Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients","status":"COMPLETED","sponsor":"University of Louisville","startDate":"2013-08","conditions":"Colorectal Cancer, Head and Neck Cancer","enrollment":24},{"nctId":"NCT05630534","phase":"PHASE1","title":"Minocycline Accelerates Intracerebral Hemorrhage Absorption","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2023-01-01","conditions":"Intracerebral Hemorrhage","enrollment":90},{"nctId":"NCT04219735","phase":"PHASE2","title":"Effect of Minocycline on Delirium Incidence in Critically Ill Patients","status":"COMPLETED","sponsor":"Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude","startDate":"2020-01-30","conditions":"Delirium, Coma","enrollment":160},{"nctId":"NCT01468831","phase":"PHASE1, PHASE2","title":"Minocycline to Treat Branch Retinal Vein Occlusion","status":"COMPLETED","sponsor":"National Eye Institute (NEI)","startDate":"2012-03-28","conditions":"Retinal Vein Occlusion","enrollment":9},{"nctId":"NCT04558502","phase":"PHASE4","title":"Effectiveness of Minocycline-Containing Bismuth Quadruple Therapy for Helicobacter Pylori Eradication","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2022-01-05","conditions":"Helicobacter Pylori Eradication","enrollment":339},{"nctId":"NCT02968602","phase":"PHASE4","title":"Minocycline and Tobacco Craving in Smokers With Schizophrenia","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2017-03-31","conditions":"Schizophrenia, Tobacco Use","enrollment":32},{"nctId":"NCT05077813","phase":"PHASE2","title":"Utilizing the Crosstalk Among Chicoric Acid, 13-Cis Retinoic Acid(Aerosolized), Minocycline and Vitamin D as a Potent Quadrate Therapy for Treating Patients With Multidrug-resistant TB and Patient With Both Multidrug-resistant TB and COVID-19","status":"UNKNOWN","sponsor":"Kafrelsheikh University","startDate":"2021-12","conditions":"Tuberculosis","enrollment":250},{"nctId":"NCT01468844","phase":"PHASE1, PHASE2","title":"Minocycline to Treat Central Retinal Vein Occlusion","status":"COMPLETED","sponsor":"National Eye Institute (NEI)","startDate":"2011-12-21","conditions":"Retinal Vein Occlusion","enrollment":6},{"nctId":"NCT04433143","phase":"NA","title":"Evaluate the Efficacy and Safety of Intense Pulsed Light Filters Combined With Oral Medication in the Treatment of Acne","status":"UNKNOWN","sponsor":"Gang Wang","startDate":"2020-05-15","conditions":"Acne Vulgaris","enrollment":60},{"nctId":"NCT03340961","phase":"PHASE2","title":"A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2017-10-01","conditions":"Rosacea","enrollment":205},{"nctId":"NCT04031755","phase":"PHASE1","title":"A Proof-of-Concept Study of Minocycline in Autism","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2019-04-19","conditions":"Autism Spectrum Disorder, Autism","enrollment":53},{"nctId":"NCT01636934","phase":"PHASE2","title":"Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2012-07","conditions":"Lung Cancer","enrollment":51},{"nctId":"NCT03340350","phase":"PHASE4","title":"Minocycline for Treatment of Posttraumatic Stress Disorder in Veterans","status":"COMPLETED","sponsor":"Sriram Ramaswamy","startDate":"2017-05-10","conditions":"PTSD","enrollment":10},{"nctId":"NCT01693523","phase":"PHASE2","title":"Minocycline Study in Pancreatic Cancer Patients","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2013-01-28","conditions":"Pancreatic Cancer","enrollment":80},{"nctId":"NCT01317550","phase":"NA","title":"A Study for Reducing Symptom Burden Produced by Chemoradiation Treatment for Non Small Cell Lung Cancer by Minocycline and Armodafinil","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2011-07","conditions":"Lung Cancer","enrollment":14},{"nctId":"NCT04036890","phase":"PHASE4","title":"Local Minocycline in Patients Under Supportive Periodontal Therapy","status":"COMPLETED","sponsor":"National Dental Centre, Singapore","startDate":"2016-06-03","conditions":"Periodontitis","enrollment":68},{"nctId":"NCT04020588","phase":"PHASE4","title":"Anti-inflammatories and Adolescent Schizophrenia","status":"UNKNOWN","sponsor":"Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico","startDate":"2019-02-25","conditions":"Schizophrenia","enrollment":90},{"nctId":"NCT01433055","phase":"NA","title":"Adjunctive Minocycline in Clozapine Treated Schizophrenia Patients","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2011-07","conditions":"Schizophrenia","enrollment":52},{"nctId":"NCT02362529","phase":"EARLY_PHASE1","title":"Biomarkers of Neuroinflammation and Anti-Inflammatory Treatments in Major Depressive Disorder","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2015-02","conditions":"Major Depressive Disorder","enrollment":115},{"nctId":"NCT02928965","phase":"PHASE2","title":"The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms","status":"COMPLETED","sponsor":"University of Manchester","startDate":"2013-02","conditions":"Schizophrenia and Disorders With Psychotic Features","enrollment":207},{"nctId":"NCT02124811","phase":"PHASE4","title":"Minocycline Augmentation to Clozapine","status":"COMPLETED","sponsor":"Emory University","startDate":"2015-02","conditions":"Schizophrenia, Schizoaffective Disorder","enrollment":10},{"nctId":"NCT01746043","phase":"PHASE2","title":"A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2013-02","conditions":"Esophageal Cancer","enrollment":22},{"nctId":"NCT00401921","phase":"PHASE2","title":"A Study of the Effects of Minocycline on Cognitive Function After Carotid Endarterectomy","status":"WITHDRAWN","sponsor":"Brigham and Women's Hospital","startDate":"2006-10","conditions":"Carotid Stenosis","enrollment":""},{"nctId":"NCT00456677","phase":"PHASE2","title":"Evaluation of the Utility of Minocycline as an Anti-Inflammatory Agent in the Treatment of Asthma","status":"COMPLETED","sponsor":"State University of New York - Downstate Medical Center","startDate":"1996-06","conditions":"Asthma","enrollment":20},{"nctId":"NCT02056665","phase":"PHASE2","title":"Study to Evaluate the Efficacy and Safety of Minocycline in Angelman Syndrome","status":"COMPLETED","sponsor":"Puerta de Hierro University Hospital","startDate":"2014-01","conditions":"Angelman Syndrome","enrollment":32},{"nctId":"NCT01938508","phase":"PHASE1","title":"Minocycline Bioequivalence Study","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-05","conditions":"Skin Diseases","enrollment":28},{"nctId":"NCT00277355","phase":"PHASE2, PHASE3","title":"Pilot Study of Minocycline in Huntington's Disease","status":"COMPLETED","sponsor":"Merit Cudkowicz","startDate":"2006-04","conditions":"Huntington Disease","enrollment":114},{"nctId":"NCT00515255","phase":"PHASE2","title":"Study of NPL-2003 in Adolescents With Obsessive Compulsive Disorder (OCD)","status":"TERMINATED","sponsor":"Neuropharm","startDate":"2007-07","conditions":"Obsessive Compulsive Disorder","enrollment":6},{"nctId":"NCT00240513","phase":"PHASE4","title":"Study Comparing Acne in Patients Taking Oral Minocycline to Patients Taking Minocycline Plus Topical Tretinoin","status":"TERMINATED","sponsor":"Derm Research @ 888 Inc.","startDate":"2004-08","conditions":"Acne Vulgaris","enrollment":38},{"nctId":"NCT01493622","phase":"PHASE4","title":"The Study of Minocycline for Negative and Cognitive Symptoms in Schizophrenia","status":"COMPLETED","sponsor":"Central South University","startDate":"2010-06","conditions":"Schizophrenia","enrollment":78},{"nctId":"NCT00893724","phase":"NA","title":"Supplemental Adjuvants for Intracellular Nutrition and Treatment","status":"UNKNOWN","sponsor":"Mid-Atlantic Retina Consultations, Inc.","startDate":"2009-06","conditions":"Neovascular Age-related Macular Degeneration, Diabetic Macular Edema","enrollment":60},{"nctId":"NCT00855062","phase":"PHASE1, PHASE2","title":"Minocycline for HIV+ Cognitive Impairment in Uganda","status":"TERMINATED","sponsor":"Johns Hopkins University","startDate":"2008-04","conditions":"HIV-associated Cognitive Impairment, HIV Infections","enrollment":73},{"nctId":"NCT00630942","phase":"PHASE1","title":"Minocycline in Primary Sclerosing Cholangitis (PSC)","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2003-02","conditions":"Primary Sclerosing Cholangitis","enrollment":16},{"nctId":"NCT00392223","phase":"PHASE3","title":"Efficacy And Safety Of Azithromycin SR Compared With Minocycline In Acne","status":"TERMINATED","sponsor":"Pfizer","startDate":"2007-10","conditions":"Acne Vulgaris","enrollment":118},{"nctId":"NCT00777413","phase":"NA","title":"Bioequivalecne Study of Minocycline 100mg Tablets Under Fed Conditions","status":"COMPLETED","sponsor":"Ranbaxy Laboratories Limited","startDate":"2002-11","conditions":"Healthy","enrollment":24},{"nctId":"NCT00776542","phase":"NA","title":"Bioequivalence Study of Minocycline 100mg Tablets Under Fasting Conditions","status":"COMPLETED","sponsor":"Ranbaxy Laboratories Limited","startDate":"2002-10","conditions":"Healthy","enrollment":28},{"nctId":"NCT00145106","phase":"PHASE4","title":"Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris","status":"COMPLETED","sponsor":"KGL, Inc.","startDate":"2002-03","conditions":"Acne Vulgaris","enrollment":189}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["DFD-29"],"phase":"phase_3","status":"active","brandName":"Minocycline hydrochloride capsules","genericName":"Minocycline hydrochloride capsules","companyName":"Beijing Tiantan Hospital","companyId":"beijing-tiantan-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Minocycline is a tetracycline antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit. Used for Bacterial infections susceptible to tetracyclines (acne, respiratory infections, urinary tract infections, rickettsial infections).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}